US Stock MarketDetailed Quotes

GLMD Galmed Pharmaceuticals

Watchlist
  • 3.2400
  • 0.00000.00%
Close Nov 4 16:00 ET
  • 3.2400
  • 0.00000.00%
Post 20:01 ET
4.88MMarket Cap-310P/E (TTM)

Galmed Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
-34.69%1.22M
-30.02%1.4M
-57.55%7.49M
-12.17%2.15M
-72.71%1.47M
-49.84%1.87M
-67.14%2M
-46.32%17.65M
-67.31%2.45M
-31.42%5.38M
Selling and administrative expenses
-35.22%688K
-16.65%766K
-15.74%3.92M
-3.83%1.03M
-19.93%912K
-7.65%1.06M
-29.09%919K
-17.75%4.66M
-12.86%1.07M
-12.65%1.14M
-General and administrative expense
-35.22%688K
-16.65%766K
-15.74%3.92M
-3.83%1.03M
-19.93%912K
-7.65%1.06M
-29.09%919K
-17.75%4.66M
-12.86%1.07M
-12.65%1.14M
Research and development costs
-33.99%534K
-41.37%635K
-72.54%3.57M
-18.65%1.12M
-86.89%556K
-68.64%809K
-77.42%1.08M
-52.26%13M
-78.00%1.38M
-35.16%4.24M
Operating profit
34.69%-1.22M
30.02%-1.4M
57.55%-7.49M
12.17%-2.15M
72.71%-1.47M
49.84%-1.87M
67.14%-2M
46.32%-17.65M
67.31%-2.45M
31.42%-5.38M
Net non-operating interest income expense
-62.95%103K
-26.74%126K
32.36%364K
-127.00%-81K
-116.67%-5K
7,050.00%278K
437.25%172K
-47.01%275K
106.90%300K
-77.10%30K
Non-operating interest income
-62.95%103K
----
26.26%375K
----
----
--278K
----
-47.15%297K
----
----
Total other finance cost
----
26.74%-126K
-50.00%11K
15,300.00%456K
116.67%5K
----
-437.25%-172K
-48.84%22K
-100.72%-3K
77.10%-30K
Other net income (expense)
144.08%216K
-366.67%-490K
Gain on sale of security
----
----
144.08%216K
----
----
----
----
-366.67%-490K
----
----
Income before tax
29.76%-1.12M
30.33%-1.28M
61.31%-6.91M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
44.97%-17.87M
64.59%-2.64M
30.65%-5.35M
Income tax
Net income
29.76%-1.12M
30.33%-1.28M
61.31%-6.91M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
44.97%-17.87M
64.59%-2.64M
30.65%-5.35M
Net income continuous Operations
29.76%-1.12M
30.33%-1.28M
61.31%-6.91M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
44.97%-17.87M
64.59%-2.64M
30.65%-5.35M
Minority interest income
Net income attributable to the parent company
29.76%-1.12M
30.33%-1.28M
61.31%-6.91M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
44.97%-17.87M
64.59%-2.64M
30.65%-5.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
29.76%-1.12M
30.33%-1.28M
61.31%-6.91M
23.61%-2.02M
72.47%-1.47M
57.34%-1.59M
70.21%-1.83M
44.97%-17.87M
64.59%-2.64M
30.65%-5.35M
Basic earnings per share
81.05%-2.16
78.70%-2.76
76.53%-30
34.67%-11.76
92.48%-2.88
57.78%-11.4
70.57%-12.96
46.21%-127.8
66.67%-18
31.40%-38.28
Diluted earnings per share
81.05%-2.16
78.70%-2.76
76.53%-30
34.67%-11.76
92.48%-2.88
57.78%-11.4
70.57%-12.96
46.21%-127.8
66.67%-18
31.40%-38.28
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense -34.69%1.22M-30.02%1.4M-57.55%7.49M-12.17%2.15M-72.71%1.47M-49.84%1.87M-67.14%2M-46.32%17.65M-67.31%2.45M-31.42%5.38M
Selling and administrative expenses -35.22%688K-16.65%766K-15.74%3.92M-3.83%1.03M-19.93%912K-7.65%1.06M-29.09%919K-17.75%4.66M-12.86%1.07M-12.65%1.14M
-General and administrative expense -35.22%688K-16.65%766K-15.74%3.92M-3.83%1.03M-19.93%912K-7.65%1.06M-29.09%919K-17.75%4.66M-12.86%1.07M-12.65%1.14M
Research and development costs -33.99%534K-41.37%635K-72.54%3.57M-18.65%1.12M-86.89%556K-68.64%809K-77.42%1.08M-52.26%13M-78.00%1.38M-35.16%4.24M
Operating profit 34.69%-1.22M30.02%-1.4M57.55%-7.49M12.17%-2.15M72.71%-1.47M49.84%-1.87M67.14%-2M46.32%-17.65M67.31%-2.45M31.42%-5.38M
Net non-operating interest income expense -62.95%103K-26.74%126K32.36%364K-127.00%-81K-116.67%-5K7,050.00%278K437.25%172K-47.01%275K106.90%300K-77.10%30K
Non-operating interest income -62.95%103K----26.26%375K----------278K-----47.15%297K--------
Total other finance cost ----26.74%-126K-50.00%11K15,300.00%456K116.67%5K-----437.25%-172K-48.84%22K-100.72%-3K77.10%-30K
Other net income (expense) 144.08%216K-366.67%-490K
Gain on sale of security --------144.08%216K-----------------366.67%-490K--------
Income before tax 29.76%-1.12M30.33%-1.28M61.31%-6.91M23.61%-2.02M72.47%-1.47M57.34%-1.59M70.21%-1.83M44.97%-17.87M64.59%-2.64M30.65%-5.35M
Income tax
Net income 29.76%-1.12M30.33%-1.28M61.31%-6.91M23.61%-2.02M72.47%-1.47M57.34%-1.59M70.21%-1.83M44.97%-17.87M64.59%-2.64M30.65%-5.35M
Net income continuous Operations 29.76%-1.12M30.33%-1.28M61.31%-6.91M23.61%-2.02M72.47%-1.47M57.34%-1.59M70.21%-1.83M44.97%-17.87M64.59%-2.64M30.65%-5.35M
Minority interest income
Net income attributable to the parent company 29.76%-1.12M30.33%-1.28M61.31%-6.91M23.61%-2.02M72.47%-1.47M57.34%-1.59M70.21%-1.83M44.97%-17.87M64.59%-2.64M30.65%-5.35M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 29.76%-1.12M30.33%-1.28M61.31%-6.91M23.61%-2.02M72.47%-1.47M57.34%-1.59M70.21%-1.83M44.97%-17.87M64.59%-2.64M30.65%-5.35M
Basic earnings per share 81.05%-2.1678.70%-2.7676.53%-3034.67%-11.7692.48%-2.8857.78%-11.470.57%-12.9646.21%-127.866.67%-1831.40%-38.28
Diluted earnings per share 81.05%-2.1678.70%-2.7676.53%-3034.67%-11.7692.48%-2.8857.78%-11.470.57%-12.9646.21%-127.866.67%-1831.40%-38.28
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------Unqualified Opinion----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data